Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Non Operating Income rose 2561.43% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2054.66%. This contributed to the annual value of $5.6 million for FY2024, which is 6148.94% up from last year.
  • Latest data reveals that Assembly Biosciences reported Non Operating Income of $1.7 million as of Q3 2025, which was up 2561.43% from $895000.0 recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Non Operating Income peaked at $1.7 million during Q3 2025, and registered a low of $58000.0 during Q1 2021.
  • For the 4-year period, Assembly Biosciences' Non Operating Income averaged around $868733.3, with its median value being $895000.0 (2025).
  • In the last 5 years, Assembly Biosciences' Non Operating Income plummeted by 9441.77% in 2021 and then soared by 17126.44% in 2024.
  • Over the past 4 years, Assembly Biosciences' Non Operating Income (Quarter) stood at $101000.0 in 2021, then skyrocketed by 1505.94% to $1.6 million in 2023, then tumbled by 30.89% to $1.1 million in 2024, then soared by 50.49% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $895000.0 for Q2 2025, and $1.1 million during Q1 2025.